Literature DB >> 842668

Dissociation of renal blood flow and filtration rate autoregulation by renin depletion.

J E Hall, A C Guyton, A W Cowley.   

Abstract

Renal blood flow (RBF) and glomerular filtration rate (GFR) autoregulation during changes in renal artery pressure (RAP) were examined in dogs fed a "normal" diet (group 1, n = 10) and in renin-depleted dogs (group 2, n = 11) which received a high-sodium diet and deoxycorticosterone acetate (DOCA) injections for a minimum of 21 days prior to the study. Renal venous plasma renin activity was undetectable in group 2 by radioimmunoassay of angiotensin I and did not increase even when RAP was reduced to less than 70 mmHg. Autoregulation of RBF was not impaired by renin depletion. However, GFR autoregulation, which was very effective in group 1 dogs, was markedly impaired in group 2. Average GFR in group 2 decreased progressively to 58 +/- 7% of the control value as RAP was reduced in steps from the control value of 137 +/- 3 to 69 +/- 1 mmHg. In normal dogs, the filtration fraction either increased slightly or did not change when RAP was reduced in steps, whereas in renin-depleted dogs the filtration fraction decreased progressively during reductions in RAP. Thus, chronic sodium loading and DOCA administration causes renin depletion and dissociates the autoregulation of RBF and GFR. These data are consistent with the hypothesis that the renin-angiotensin system participates in the control of GFR, possibly by an efferent arteriolar mechanism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 842668     DOI: 10.1152/ajprenal.1977.232.3.F215

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Autoregulation of the glomerular filtration rate and the single-nephron glomerular filtration rate despite inhibition of tubuloglomerular feedback in rats chronically volume-expanded by deoxycorticosterone acetate.

Authors:  D A Häberle; B Königbauer; J M Davis; T Kawata; C Mast; C Metz; H Dahlheim
Journal:  Pflugers Arch       Date:  1990-07       Impact factor: 3.657

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  The control of glomerular filtration rate and renal blood flow in chronically volume-expanded rats.

Authors:  J M Davis; D A Häberle; T Kawata
Journal:  J Physiol       Date:  1988-08       Impact factor: 5.182

4.  A comparison of the ability of two angiotensin II receptor blocking drugs, 1-Sar; 8-Ala angiotensin II and 1-Sar, 8-Ile angiotensin II, to modify the regulation of glomerular filtration rate in the cat.

Authors:  E J Johns
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  Long-term effect of captopril on kidney function in various forms of hypertension.

Authors:  W Vetter; M Wehling; E C Foerster; U Kuhlmann; H J Boerlin; P Greminger; H Vetter
Journal:  Klin Wochenschr       Date:  1984-08-01

6.  Action of GABA on mammalian peripheral nerves [proceedings].

Authors:  D A Brown; S Marsh
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

7.  Calcium ion dependence of myogenic renal plasma flow autoregulation: evidence from the isolated perfused rat kidney.

Authors:  A J Cohen; J C Fray
Journal:  J Physiol       Date:  1982-09       Impact factor: 5.182

8.  Interaction of the renin-angiotensin system and the renal nerves in the regulation of rat kidney function.

Authors:  R K Handa; E J Johns
Journal:  J Physiol       Date:  1985-12       Impact factor: 5.182

9.  Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.

Authors:  O O Thomsen; H Danielsen; S S Sørensen; E B Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Effect of converting enzyme inhibition on the renal haemodynamic responses to noradrenaline infusion in the rat.

Authors:  L A Arundell; E J Johns
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.